BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Somatic Cell Gene Editing - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Somatic Cell Gene Editing
X-ORIGINAL-URL:https://scge.mcw.edu
X-WR-CALDESC:Events for Somatic Cell Gene Editing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230129
DTEND;VALUE=DATE:20230202
DTSTAMP:20260410T182032
CREATED:20221020T162656Z
LAST-MODIFIED:20221020T162656Z
UID:2680-1675015200-1675274399@scge.mcw.edu
SUMMARY:3rd TGF-β for Immuno-Oncology Drug Development Summit
DESCRIPTION:In the past year alone\, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine. \nFrom uncovering the effects and production of TGF-β in immune\, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures\, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β. \nTailored with 18+ senior leaders\, the 2023 meeting will be taking place in-person for the first time – don’t miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology! \nWhether you are new to this field or a seasoned expert\, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.
URL:https://scge.mcw.edu/events/3rd-tgf-%ce%b2-for-immuno-oncology-drug-development-summit/
LOCATION:Marines’ Memorial Club & Hotel\, 609 Sutter St\, San Francisco\, CA\, 94102\, United States
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2022/10/Capture-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230129
DTEND;VALUE=DATE:20230202
DTSTAMP:20260410T182032
CREATED:20221027T165045Z
LAST-MODIFIED:20221027T165045Z
UID:2763-1675015200-1675274399@scge.mcw.edu
SUMMARY:2nd Allogeneic Cell Therapies Summit Europe
DESCRIPTION:Allogeneic approaches are deemed the future of cell therapy due to their potential to reduce costs\, increase accessibility and enhance availability. However as clinical readouts emerge\, challenges associated with limited durability\, solid tumour targeting and therapy immunogenicity are hindering their efficacies. \nThe Allogeneic Cell Therapies Summit Europe is returning in January to capture the clinical advances of European drug developers whilst addressing the specific challenges they face in development. These include European regulatory affairs\, donor selection\, scalable manufacturing and therapy persistence. \nWith continued investment and growth in the allogeneic space\, join European leaders from Gadeta\, Antion Biosciences\, TC BioPharm\, and many more\, as well as the US leaders undertaking European trials. This includes Atara Bio and Adicet Bio\, as they progress development of multiple cell types to produce the next-generation of safe\, effective and accessible cell therapies in Europe.
URL:https://scge.mcw.edu/events/2nd-allogeneic-cell-therapies-summit-europe/
LOCATION:Leonardo Royal London City\, 8-14 Cooper's Row\, London\, EC3N 2BQ\, United Kingdom
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2022/10/Capture-25.png
END:VEVENT
END:VCALENDAR